|
1
|
Allison KH, Brogi E, Ellis IO, Fox SB,
Morris EA, Sahin A, Salgado R, Sapino A, Sasano H, Schnitt SJ, et
al: World Health Organization classification of tumours editorial
board. Breast tumors. 5th edition. IARC Press; Lyon: 2019
|
|
2
|
Hoda SA, Brogi E, Koerner FC and Rosen PP:
Rosen's Breast Pathology. 4th edition. Lippincott Williams &
Wilkins; Philadelphia, PA: 2014
|
|
3
|
Spitaleri G, Toesca A, Botteri E,
Bottiglieri L, Rotmensz N, Boselli S, Sangalli C, Catania C,
Toffalorio F, Noberasco C, et al: Breast phyllodes tumor: A review
of literature and a single center retrospective series analysis.
Crit Rev Oncol Hematol. 88:427–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeng S, Zhang X, Yang D, Wang X and Ren G:
Effects of adjuvant radiotherapy on borderline and malignant
phyllodes tumors: A systematic review and meta-analysis. Mol Clin
Oncol. 3:663–671. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fede ÂBS, Pereira Souza R, Doi M, De Brot
M, Aparecida Bueno de Toledo Osorio C, Rocha Melo Gondim G,
Casali-da-Rocha JC, Jbili R, Bitencourt AGV, Alves de Souza J, et
al: Malignant pyllodes tumor of the breast: A practice review. Clin
Pract. 11:205–215. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu J and Kansal K: Management of Stromal
Lesions. Surg Clin North Am. 102:1017–1030. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 44:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Penkert J, Ripperger T, Schieck M,
Schlegelberger B, Steinemann D and Illig T: On metabolic
reprogramming and tumor biology: A comprehensive survey of
metabolism in breast cancer. Oncotarget. 7:67626–67649. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun X, Wang M, Wang M, Yao L, Li X, Dong
H, Li M, Sun T, Liu X, Liu Y and Xu Y: Role of proton-coupled
monocarboxylate transporters in cancer: From metabolic crosstalk to
therapeutic potential. Front Cell Dev Biol. 8:6512020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stine ZE, Schug ZT, Salvino JM and Dang
CV: Targeting cancer metabolism in the era of precision oncology.
Nat Rev Drug Discov. 21:141–162. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mostafavi S, Zalpoor H and Hassan ZM: The
promising therapeutic effects of metformin on metabolic
reprogramming of cancer-associated fibroblasts in solid tumors.
Cell Mol Biol Lett. 27:582022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pinheiro C, Albergaria A, Paredes J, Sousa
B, Dufloth R, Vieira D, Schmitt F and Baltazar F: Monocarboxylate
transporter 1 is up-regulated in basal-like breast carcinoma.
Histopathology. 56:860–867. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Witkiewicz AK, Whitaker-Menezes D,
Dasgupta A, Philp NJ, Lin Z, Gandara R, Sneddon S,
Martinez-Outschoorn UE, Sotgia F and Lisanti MP: Using the ‘reverse
Warburg effect’ to identify high-risk breast cancer patients:
Stromal MCT4 predicts poor clinical outcome in triple-negative
breast cancers. Cell Cycle. 11:1108–1117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martins D, Beça FF, Sousa B, Baltazar F,
Paredes J and Schmitt F: Loss of caveolin-1 and gain of MCT4
expression in the tumor stroma: Key events in the progression from
an in situ to an invasive breast carcinoma. Cell Cycle.
12:2684–2690. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Johnson JM, Cotzia P, Fratamico R,
Mikkilineni L, Chen J, Colombo D, Mollaee M, Whitaker-Menezes D,
Domingo-Vidal M, Lin Z, et al: MCT1 in invasive ductal carcinoma:
Monocarboxylate metabolism and aggressive breast cancer. Front Cell
Dev Biol. 5:272017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yeong J, Thike AA, Ikeda M, Lim JCT, Lee
B, Nakamura S, Iqbal J and Tan PH: Caveolin-1 expression as a
prognostic marker in triple negative breast cancers of Asian women.
J Clin Pathol. 71:161–167. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao S, Zhu H, Shi Y, Wu Z, Wu H and Xie
M: Prognostic and predictive value of monocarboxylate transporter 4
in patients with breast cancer. Oncol Lett. 20:2143–2152. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agelopoulos K, Kersting C, Korsching E,
Schmidt H, Kuijper A, August C, Wülfing P, Tio J, Boecker W, van
Diest PJ, et al: Egfr amplification specific gene expression in
phyllodes tumours of the breast. Cell Oncol. 29:443–451.
2007.PubMed/NCBI
|
|
20
|
Kwon JE, Jung WH and Koo JS: The
expression of metabolism-related proteins in phyllodes tumors.
Tumour Biol. 34:115–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim GE, Kim JH, Lee KH, Choi YD, Lee JS,
Lee JH, Nam JH, Choi C, Park MH and Yoon JH: Stromal matrix
metalloproteinase-14 expression correlates with the grade and
biological behavior of mammary phyllodes tumors. Appl
Immunohistochem Mol Morphol. 20:298–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Payen VL, Mina E, Van Hée VF, Porporato PE
and Sonveaux P: Monocarboxylate transporters in cancer. Mol Metab.
33:48–66. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Parton RG, McMahon KA and Wu Y: Caveolae:
Formation, dynamics, and function. Curr Opin Cell Biol. 65:8–16.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Williams TM and Lisanti MP: The Caveolin
genes: From cell biology to medicine. Ann Med. 36:584–595. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Z, Gao Z, Rajthala S, Sapkota D,
Dongre H, Parajuli H, Suliman S, Das R, Li L, Bindoff LA, et al:
Metabolic reprogramming of normal oral fibroblasts correlated with
increased glycolytic metabolism of oral squamous cell carcinoma and
precedes their activation into carcinoma associated fibroblasts.
Cell Mol Life Sci. 77:1115–1133. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pinheiro C, Penna V, Morais-Santos F,
Abrahão-Machado LF, Ribeiro G, Curcelli EC, Olivieri MV, Morini S,
Valença I, Ribeiro D, et al: Characterization of monocarboxylate
transporters (MCTs) expression in soft tissue sarcomas: Distinct
prognostic impact of MCT1 sub-cellular localization. J Transl Med.
12:1182014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jensen DH, Therkildsen MH and Dabelsteen
E: A reverse Warburg metabolism in oral squamous cell carcinoma is
not dependent upon myofibroblasts. J Oral Pathol Med. 44:714–721.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wiechen K, Sers C, Agoulnik A, Arlt K,
Dietel M, Schlag PM and Schneider U: Down-regulation of caveolin-1,
a candidate tumor suppressor gene, in sarcomas. Am J Pathol.
158:833–839. 2001. View Article : Google Scholar : PubMed/NCBI
|
